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Abstract
Lyme disease is caused by a bacteria belonging to the Borreliaceae family. Wooded forests and terrains
are affected, including those in the Northeastern United States. Teenage ticks are most commonly
discovered on humans as those ticks need to satisfy their nutritional requirements for growth. They bite
warm, moist areas of the body and take 24 to 48 hours to transmit the Borrelia Burgdorferi infection. Lyme
disease manifests as a multisystem disorder in humans, and is known for its dermatological, neurological
and rheumatological findings. For the primary care provider, Lyme disease should be on the differential in
multisystem diseases. Our case is a 63 year old gentleman who presented with unilateral knee pain for
the last 3 months. He initially visited the outpatient orthopedic outpatient office for this arthritic pain.
Before moving forward with knee replacement he was eventually tested for Lyme Serology IgG and IgM
tests. His positive results warranted Lyme Western Blot testing which confirmed the suspicion of lyme
arthritis secondary to Borrelia Burgdorferi. He was treated with a 14 day course of doxycycline, which
resulted in significant improvement of knee pain and return to baseline functionality without surgical
intervention. The purpose of this report is to stress the importance of beginning doxycycline as soon as
possible to avoid progression into other organ systems such as worsening rheumatologic arthritis, central
nervous system neuropathies, peripheral nervous system palsies, or cardiac atrioventricular blocks. The
optimal treatment is obtained with thorough history taking and physical examination.
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Introduction
Lyme disease is caused by a bacteria belonging to the Borreliaceae family. In North America, B.
burgdorferi is the most common species known to cause infection. Wooded forests and terrains
are affected, including those in the Northeastern United States.1 The Ixodes scapularis tick
transmits the spirochete through vectors such as rodents, cats and deer. Teenage ticks are most
commonly discovered on humans as those ticks need to satisfy their nutritional requirements for
growth. They bite warm, moist areas of the body and take 24 to 48 hours to transmit the Borrelia
burgdorferi infection.2 Lyme disease manifests as a multisystem disorder in humans, and is known
for its dermatologic, neurological and rheumatological findings. The goal of this brief review is
to provide a framework for primary care physicians to guide the evaluation for Lyme disease.
Typical Case Presentation in the Ambulatory Setting
A 63-year old male with a past medical history notable for coronary artery disease, diabetes
mellitus type 2, and obstructive sleep apnea requiring CPAP, presented with unilateral knee pain
for the last 3 months. The worsening pain was associated with knee swelling, warmth and redness.
The left knee arthritis affects his gait mobility and decreases his daily activities. He initially visited
the outpatient orthopedic outpatient office for this arthritic pain. He was asked to visit the primary
care office before x-ray or surgery consultation for knee replacement. At the primary care office,
he discussed living in the countryside with two dogs, one of which was recently diagnosed with
Lyme disease.
Before moving forward with knee replacement, the differential of unilateral knee swelling
was evaluated, including: normal complete blood count and basic metabolic profile; negative
ANA; a non-diagnostic x-ray; and an arthrocentesis, which revealed trace leukocytes, no crystals,
and no purulent fluid. Gout, septic arthritis (including gonorrheal infection), osteoarthritis, and
rheumatoid arthritis were ruled out. Positive tests on Lyme serology, both IgG and IgM, warranted
Lyme Western Blot testing, which confirmed the suspicion of Lyme arthritis secondary to B.
burgdorferi. He was treated with a 14-day course of doxycycline, which resulted in significant
improvement of knee pain and return to baseline functionality without surgical intervention.
Discussion
Lyme disease may be missed on the differential diagnosis when multiple systems are involved
over time and discovering it requires a thorough history and physical. (Table) In the above case,
the history of living in the countryside and outdoor activities were enough information for the
caretaking physician to perform Lyme serology testing. Diagnosis can be difficult without
obvious external signs, such as the classic erythema migrans rash, which was not seen in this
case. Targeted history taking is paramount to avoid unnecessary procedures.
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Stage

Onset Time

Manifestation

Dermatologic

Within 3 months of
infection

•
•
•

Erythema Migrans
Borrelial lymphocytoma (rare)
Acrodermatitis chronica

Musculoskeletal

Often after 6 months
of infection

•

Muscle pain, joint pain (knee most
commonly affected)
Chronic arthritis (patients positive for
HLA-DR4/DR2 more at risk)

•
Cardiovascular

Several weeks to
months after infection

•
•

Central Nervous
System

Months-Years after
infection

•
•
•
•
•

a

Conduction abnormalities, especially
atrioventricular blocks
Exudative pericarditis
Bannwarth Syndrome (lymphocytic
meningitis with radicular pain)
Radicular Pain (usually worse at night)
Cranial Nerve Palsy (most commonly
facial nerve)
Visual disturbances
Encephalopathy

Adapted from Biesiada, et al.1

Lyme disease affects the integumentary system with the erythema migrans (EM)
‘bullseye’ rash. There is an initial uniform circular pattern of erythema from accumulation of B.
burgdorferi. The body’s immune and inflammatory systems begin to clear away the organisms
and create the central clearing seen in Lyme disease; however, the classical EM rash is not
always present at the time of evaluation.2 Aucott et al. in their retrospective analysis of a panel of
patients in a community based practice found that 13% of patients diagnosed with Lyme disease
did not present with a rash, and amongst those patients who did have a rash, the diagnosis of EM
was initially missed in 23% of patients.3
There are at least 11 genostrains of B. burgdorferi currently known.4 Most immunoblot
testing is based on the B31 lab strain. Genetic variability among strains, including variance of
outer surface proteins (Osp), in part accounts for a lack of detection on serological testing.5 The
CDC criteria excludes OspA and OspB, in spite of rising numbers of these variants.5 This is
further compounded by the introduction of genetic variants by vectors such as migratory birds.
Lyme disease commonly affects the musculoskeletal system with an arthritis of knee
joints. Classically, there is involvement of one knee joint rather than bilateral swelling. In the
1970’s, lyme arthritis was first seen in an outbreak of monoarticular arthritis in children in Lyme,
Connecticut.6 It is a late disease manifestation, months after the initial infection, and the arthritic
symptoms can last anywhere between days and many years.
Long-standing arthritis is associated with immune resistance by the organism and failure
to decrease inflammation of that immune response even after Lyme disease disappears. Arthritis
pathophysiology is explained by inflammation secondary to the immune system producing
antibodies to phagocytize the spirochetes.6 It is associated specifically with HLA-DR alleles that
bind an epitope of B. burgdorferi outer-surface protein A (OspA) which initiates a strong T
helper cell 1 response. The T cell reaction is secondary to a TLR1 polymorphism (1805GG) that
is found in half of the European Caucasian population which leads to the exaggerated release of
cytokines and chemokines in affected joints. In the synovial fluid of knee joints, there are lower
frequencies of the FoxP3+ T cells resulting in increased duration for Lyme eradication.7 Not only
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are there fewer T cells, but cartilage is known to have decreased vascular supply. Therefore,
immune responses take longer for synovial fluid targeting.
Lyme disease affects both the central and peripheral nervous systems. JozefowiczKorczynska, et al., in their review of 13 cases of Lyme disease, found that central nervous
system involvement, termed neuroborreliosis, may present with symptoms such as meningitis,
vertigo, dizziness, tinnitus, and hearing loss.7 Peripheral nerve involvement includes facial nerve
Bell’s palsy. A Lyme disease presentation as lymphocytic meningoradiculitis, known as
Bannwarth syndrome, is almost exclusively seen in Europe.8 This is most often implicated with
the subtype, B. garinii. Bannwarth syndrome is characterized by the triad of painful
radiculopathy, cranial neuropathy, and lymphocytic pleocytosis.8 Diagnosis is made by
cerebrospinal fluid analysis for IgG/IgM antibodies to B. burgdorferi. Although there is central
nervous system involvement, patients commonly do not experience meningeal signs of neck
stiffness, headache or vomiting. Therefore, appropriate history can lead to cerebrospinal fluid
analysis to confirm Bannwarth syndrome.
Testing for Lyme disease consists of Lyme IgG and IgM Serological testing. A positive
B. burgdorferi IgG test reports 5 or more bands of 18, 23, 28, 30, 39, 41, 45, 58, 66 or 93 kDa
and a positive B. Burgdorferi IgM test reports 2 or more bands of 23, 39 or 41 kDa.9 Positive
serological testing is confirmed with Western Blot Lyme testing. Lyme IgG and IgM serological
testing can be negative in up to 60% of patients with 1 week of infection, so history and physical
exam direct toward correct diagnosis.10 Serology for Lyme arthritis is often positive before
treatment and negative after the treatment.
Treatment for Lyme disease consists of a 14 day course of doxycycline or amoxicillin.
During the course of disease, a negative IgG or IgM Lyme Serology test does not stop
management course due to the relatively low 60% test sensitivity.11 Even with a negative test,
continue doxycycline treatment for a total 14 day course and confirm with Lyme Western Blot
test returns. In addition, tetracycline is teratogenic in pregnant women and should be avoided in
this population.
If Lyme disease remains untreated, within 2 weeks of infection, it can progress to serious
complications including heart block, neurologic symptoms and severe arthritis. For these late
disease Lyme cases, starting ceftriaxone for a 14 day course can prevent further progression.12
Ceftriaxone is not meant to treat current symptoms, but rather to stop 2nd degree heart blocks
from converting into complete dissociation of atria and ventricles.12
Post-treatment complications are part of a symptom complex known as post-infective
syndrome, also dubbed Post Treatment Lyme Disease Syndrome.12 Patients may suffer from
symptoms such as joint pain, insomnia, and impaired cognition even after treatment with
antibiotics. These pose important implications for patients with joint pain as many individuals
may go on to develop disturbances in gait, strength, and overall functionality if infections are not
treated in a time- sensitive manner.12
Conclusion
For the primary care provider, Lyme disease should be on the differential in multisystem
diseases. The presentation of arthritis without EM or specific attachment of a tick warrants
targeted questioning about outdoor activities and hobbies. Physical exam is useful for identifying
the classical EM rash, the arthritic swelling, and nerve palsies. Begin doxycycline as soon as
possible to avoid progression into other organ systems such as worsening underlying arthritis,
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central nervous system neuropathies, peripheral nervous system palsies, or cardiac
atrioventricular blocks. Do not change management based on serology IgG or IgM Lyme tests,
but rather based on clinical suspicion, and be aware of the manifestation of Lyme disease in each
system.
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